Page last updated: 2024-11-04

sevoflurane and Animal Mammary Carcinoma

sevoflurane has been researched along with Animal Mammary Carcinoma in 1 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Research Excerpts

ExcerptRelevanceReference
"Sevoflurane treatments modified the cell proliferation rate in both cell lines showing an increase or decrease when applied to CIPp or CIPm, respectively."1.51Canine mammary tumour cells exposure to sevoflurane: effects on cell proliferation and neuroepithelial transforming gene 1 expression. ( Argano, M; Buracco, P; De Maria, R; Larenza Menzies, MP; Rodlsberger, K; Vogl, C, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Argano, M1
De Maria, R1
Vogl, C1
Rodlsberger, K1
Buracco, P1
Larenza Menzies, MP1

Other Studies

1 other study available for sevoflurane and Animal Mammary Carcinoma

ArticleYear
Canine mammary tumour cells exposure to sevoflurane: effects on cell proliferation and neuroepithelial transforming gene 1 expression.
    Veterinary anaesthesia and analgesia, 2019, Volume: 46, Issue:3

    Topics: Adenocarcinoma; Anesthetics; Animals; Cell Line, Tumor; Cell Proliferation; Colorimetry; Dog Disease

2019